Search Results - "Boddu, Rajkumar"

Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?

Authors: Kollipara, Sivacharan Boddu, Rajkumar Uppuluri, Chandra Teja et al.

Source: Pharmaceutics. May2026, Vol. 18 Issue 5, p536. 27p.

Model integrated evidence approach for rational and safe formulation development: case of alfuzosin prolonged-release tablets.

Authors: Kollipara, Sivacharan Boddu, Rajkumar Bonda, Suribabu et al.

Source: Journal of Applied Pharmaceutical Science. Jun2025, Vol. 15 Issue 6, p253-264. 12p.

Novel omeprazole delayed release orally disintegrating tablets for enhanced patient compliance: a case of model informed formulation development.

Authors: Boddu, Rajkumar Kollipara, Sivacharan Kambam, Veena et al.

Source: Xenobiotica. Sep2024, Vol. 54 Issue 9, p629-641. 13p.

Novel application of PBBM to justify impact of faster dissolution on safety and pharmacokinetics – a case study and utility in regulatory justifications.

Authors: Boddu, Rajkumar Kollipara, Sivacharan Bhattiprolu, Adithya Karthik et al.

Source: Xenobiotica. Oct/Nov2023, Vol. 53 Issue 10/11, p587-602. 16p.

Power of integrating PBPK with PBBM (PBPK-BM): a single model predicting food effect, gender impact, drug-drug interactions and bioequivalence in fasting & fed conditions.

Authors: Boddu, Rajkumar Kollipara, Sivacharan Vijaywargi, Gautam et al.

Source: Xenobiotica. Apr2023, Vol. 53 Issue 4, p260-278. 19p.

Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling.

Authors: Bhattiprolu, Adithya Karthik Kollipara, Sivacharan Boddu, Rajkumar et al.

Source: Xenobiotica. Oct2024, Vol. 54 Issue 10, p781-795. 15p.

Development of an In Vitro-In Vivo Correlation for Sitagliptin and Metformin Prolonged-release Tablet Formulations.

Alternate Title: Sitaglipin ve Metformin Uzatılmış Salınımlı Tablet Formülasyonları İçin İn Vitro-İn Vivo Korelasyon Geliştirme.

Authors: BODDU, Rajkumar VADLA, Harikiran Chary PRATHAP, Vamshi Ramana et al.

Source: Turkish Journal of Pharmaceutical Sciences. Apr2021, Vol. 18 Issue 2, p233-241. 9p.

New era in bioequivalence global harmonization through ICH M13 initiative: critical review on new concepts, alternative approaches for high-risk products.

Authors: Khan, Mohammed Shareef Khan, Sohel Mohammed Martins, Frederico Severino et al.

Source: Xenobiotica. Jun2025, Vol. 55 Issue 6, p464-477. 14p.

STABILITY INDICATING METHOD DEVELOPMENT OF RP-UPLC, VALIDATION OF SIMULTANEOUS QUANTITATION OF BUPIVACAINE and MELOXICAM IN PURE AND FORMULATION.

Authors: Rani, J. David Blessing Deepti, C. Asha

Source: Rasayan Journal of Chemistry. Jul-Sep2023, Vol. 16 Issue 3, p1359-1368. 10p.

Plants, animals, and fisheries waste-mediated bioremediation of contaminants of environmental and emerging concern (CEECs)—a circular bioresource utilization approach.

Authors: Krishnani, Kishore Kumar Boddu, Veera Mallu Singh, Rajkumar Debarjeet et al.

Source: Environmental Science & Pollution Research. Aug2023, Vol. 30 Issue 36, p84999-85045. 47p.

Simultaneous Quantification of Paracetamol and Meloxicam in Tablets by High Performance Liquid Chromatography.

Authors: Induri, Madhusudhanareddy Mantripragada, Bhagavan R. Yejella, Rajendra P. et al.

Source: Tropical Journal of Pharmaceutical Research. Aug2011, Vol. 10 Issue 4, p475-481. 7p. 1 Diagram, 3 Charts, 1 Graph.